Hyper-IgM Syndrome (HIGM): (AICDA for HIGM2) (Full Gene Sequencing)

CPT: 81479
Print Share

Test Includes

This test covers all coding nucleotides of gene AICDA, plus at least two and typically 20 flanking intronic nucleotides upstream and downstream of each coding exon, covering the conserved donor and acceptor splice sites, as well as typically 20 flanking nucleotides in the 5′ and 3′ UTR.


Special Instructions

In cases in which a known mutation can be documented, the physician may prefer to order test 252663.


Expected Turnaround Time

18 - 35 days


Related Documents


Specimen Requirements


Specimen

Whole blood; DNA is accepted (Call 866-647-0735 for DNA collection information.)


Volume

2 mL


Container

Lavender-top (EDTA) tube


Collection

Samples may be stored for brief periods at 4°C. Ship overnight at room temperature.


Storage Instructions

Maintain specimen at room temperature.


Causes for Rejection

Container broken or leaking; container not labeled or label not legible; improper anticoagulant


Test Details


Use

Confirm a clinical diagnosis of HIGM; detect carriers; allow early diagnosis in family members, guiding prophylactic measures


Limitations

This method does not reliably detect mosaic variants; large deletions; large duplications, inversions, or other rearrangements; or deep intronic variants. It may be affected by allele-dropout, it may not allow determination of the exact numbers of T/A or microsatellite repeats, and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.

Results of this test are for investigational purposes only. The performance characteristics of this assay have been determined by LabCorp. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.


Methodology

DNA sequencing


Reference Interval

Normal equals reference sequence or variants that are known or predicted to be benign; abnormal equals all other variants.


Additional Information

Hyper immunoglobulin M syndrome type 2 (HIGM2) is a recessively inherited immune disorder characterized by lack of IgG, IgA, and IgE in the presence of excess IgM, leading to increased susceptibility to bacterial infections. In addition, HIGM2 is associated with an increased risk of autoimmunity. Mutations in AICDA account for all of HIGM2 and about 30% of HIGM overall. Genetic testing can confirm a clinical diagnosis of HIGM2 and detect mutation carriers within affected families.


References

Durandy A, Revy P, Imai K, et al. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.Immunol Rev. 2005 Feb; 203:67-79. 15661022

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
252425 HIGM2:AICDA 41103-3 252194 Routing 41103-3

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf